Your session is about to expire
← Back to Search
Behavioural Intervention
SAM App for Medication Adherence
N/A
Recruiting
Research Sponsored by Robyn Tamblyn
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Covered by provincial (RAMQ) prescription drug insurance plan
Covered by provincial (RAMQ) health insurance plan
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days post-discharge
Awards & highlights
Study Summary
This trial will evaluate a new mobile app to reduce post-discharge hospital visits, readmissions & death by targeting medication nonadherence & use of potentially inappropriate medications.
Who is the study for?
The SAM trial is for patients who speak English or French, have provincial health and prescription insurance, own a smart device with internet, and had a medication change at hospital discharge. It excludes those sent to rehab or transferred to non-study units.Check my eligibility
What is being tested?
This study tests the SAM app designed to help patients stick to their new medication plans after leaving the hospital. The app shows updated meds lists with pictures, checks for side effects and interactions, and warns about inappropriate meds.See study design
What are the potential side effects?
Since this trial involves using an application rather than a drug, traditional side effects are not expected. However, there may be indirect consequences if the app fails to prevent medication errors or if reliance on technology affects patient behavior.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My prescription drugs are covered by provincial insurance.
Select...
I am covered by provincial health insurance.
Select...
I can speak and read English or French.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days post-discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days post-discharge
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
ED visits, hospital readmissions, and deaths (composite)
Secondary outcome measures
Nonadherence to medication changes
Patient and caregiver empowerment
Patient health-related quality of life
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (SAM app)Experimental Treatment1 Intervention
Patients will receive training in and access to the SAM app at discharge. SAM uses prescribed and dispensed medication data to display a continuously updated drug list and provides patients and caregivers with tools to address barriers to adherence.
Drug information: Provides patient-friendly drug monographs. Interaction checker: Generates drug-drug interactions between the patient's medications and other OTC drugs.
Adherence alerts: Uses decision algorithms to alert users to adherence problems with the new regimen.
Side effect checker: Displays possible side effects for each medication and frequency of occurrence.
PIMs alerts: Alerts patients to potentially inappropriate medications in their list.
Pharmacist connect: Connects users with pharmacists through a secured messaging service.
Social connect: Allows users to share medication experiences. Caregiver connect: Allows patients to enroll caregivers who can use the app. Weekly medication schedule & pill reminders
Group II: Control (usual care)Active Control1 Intervention
Patients will receive usual care at discharge. On study units, medication reconciliation is conducted for all patients. Patients have their community medication list obtained via fax from their community pharmacy. The list is validated by the unit pharmacist who then reconciles it with admission orders, and recommends changes as needed to the attending physician. At discharge, the community drug list is reconciled with medications administered in hospital and the discharge prescription is generated by the attending physician or resident, classifying each medication as new medication, dose modification, discontinued therapy, or continued community medication. The discharge prescription is provided to the patient. Patients fill their discharge prescription at their community pharmacy. If there are questions about changes to the community drug list, the pharmacist will ask the patient, and if not clear will contact the discharging physician.
Find a Location
Who is running the clinical trial?
Robyn TamblynLead Sponsor
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,450,367 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My medication was changed when I was last discharged from the hospital.I was sent to rehab after hospital discharge.My prescription drugs are covered by provincial insurance.I am covered by provincial health insurance.I can speak and read English or French.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention (SAM app)
- Group 2: Control (usual care)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers currently recruiting participants for this experiment?
"Affirmative. According to clinicaltrials.gov, this medical experiment initiated on February 1st 2023 and was last revised May 8th 2023 is currently recruiting individuals for participation. Across a single location, 3200 patients are sought after."
Answered by AI
How many people have joined this clinical experiment thus far?
"Confirmed, the trial's entry on clinicaltrials.gov verifies that it is actively recruiting patients as of May 8th 2023. First posted on February 1st 2023, this research initiative seeks 3200 participants from a single medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger